Cargando…
P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431018/ http://dx.doi.org/10.1097/01.HS9.0000971572.32493.7a |
| _version_ | 1785091099272937472 |
|---|---|
| author | Ip, Andrew Rosenthal, Allison Mutebi, Alex Wang, Tongsheng Jun, Monika Wang, Anthony Yu, Junhua Brodkin, Samantha Sacchi, Mariana Kalsekar, Anupama Munoz, Javier |
| author_facet | Ip, Andrew Rosenthal, Allison Mutebi, Alex Wang, Tongsheng Jun, Monika Wang, Anthony Yu, Junhua Brodkin, Samantha Sacchi, Mariana Kalsekar, Anupama Munoz, Javier |
| author_sort | Ip, Andrew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431018 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310182023-08-17 P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY Ip, Andrew Rosenthal, Allison Mutebi, Alex Wang, Tongsheng Jun, Monika Wang, Anthony Yu, Junhua Brodkin, Samantha Sacchi, Mariana Kalsekar, Anupama Munoz, Javier Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431018/ http://dx.doi.org/10.1097/01.HS9.0000971572.32493.7a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ip, Andrew Rosenthal, Allison Mutebi, Alex Wang, Tongsheng Jun, Monika Wang, Anthony Yu, Junhua Brodkin, Samantha Sacchi, Mariana Kalsekar, Anupama Munoz, Javier P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title | P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title_full | P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title_fullStr | P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title_full_unstemmed | P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title_short | P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY |
| title_sort | p1169: comparison of real-world clinical outcomes in patients with relapsed/refractory large b-cell lymphoma treated with epcoritamab vs chemoimmunotherapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431018/ http://dx.doi.org/10.1097/01.HS9.0000971572.32493.7a |
| work_keys_str_mv | AT ipandrew p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT rosenthalallison p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT mutebialex p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT wangtongsheng p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT junmonika p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT wanganthony p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT yujunhua p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT brodkinsamantha p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT sacchimariana p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT kalsekaranupama p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy AT munozjavier p1169comparisonofrealworldclinicaloutcomesinpatientswithrelapsedrefractorylargebcelllymphomatreatedwithepcoritamabvschemoimmunotherapy |